Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer (BC) (accounting for 10–20% of all BCs) that is characterized by the absence of hormone receptors and has limited therapeutic options. The gene discussed is NR4A1; the disease is breast cancer.